<DOC>
	<DOCNO>NCT00936845</DOCNO>
	<brief_summary>To collect analyze data female hemophilia good define difference study population male population hemophilia .</brief_summary>
	<brief_title>Females With Severe Moderate Hemophilia A B : A Multi-Center Study</brief_title>
	<detailed_description>This study design epidemiological study retrospective clinical genetic data collection prospective quality life ( QOL ) data collection genotyping subject without current molecular diagnosis . Data genetic/chromosomal etiology condition collect chart review . For subject molecular cytogenetic analysis , molecular cytogenetic testing offer genetic counseling . Those subject agree genetic test 5-10 ml blood drawn send cytogenetic laboratory Weill Cornell Medical College test determine chromosomal complement , 5 ml blood send Dr. Arupa Ganguly University Pennsylvania identification factor VIII factor IX mutation , X-chromosome inactivation study .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Females severe ( FVIII &lt; 0.01u/dl ) moderate ( FVIII0.01 &lt; 0.06 u/dl ) hemophilia A Females severe ( FIX &lt; 0.01u/dl ) moderate ( FIX0.01 &lt; 0.06u/dl ) hemophilia B Willingness participate study . Subjects meet inclusion criterion respect gender hemophilia severity .</criteria>
	<gender>Female</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>